Biological therapies for premature ovarian insufficiency: what is the evidence?
Premature Ovarian Insufficiency (POI) is a multi-factorial disorder that affects women of reproductive age.The condition is characterized by the loss of ovarian function before the age of 40 years and several factors have been identified Requests to be implicated in its pathogenesis.Remarkably though, at least 50% of women have remaining follicles